Skip to main content

NIH Plans to Purchase MiSeq for Library-Prep QC for HiSeq Experiments


The National Heart, Lung, and Blood Institute plans to purchase an Illumina MiSeq instrument, according to a notice of intent posted on the Federal Business Opportunities site earlier this month.

NHLBI said in the notice that the MiSeq, which is being purchased on behalf of the National Human Genome Research Institute, would be used for library-prep quality control for experiments run on the Illumina HiSeq 2000, among other applications.

Using the MiSeq for library-prep quality control will help "reduce failures and costly repeats," and provide a "more accurate cell titer of the library sample before it is loaded onto the HiSeq sequencer, which is more expensive to run," NHLBI said.

James Hadfield, head of the genomics core facility at the Cambridge Research Institute, also plans to use the instrument to check the quality of sequencing libraries before running them through the HiSeq (IS 9/20/2011).

The NHLBI notice of intent added that the MiSeq is easy to use and does not require emulsion PCR, allowing for a "self-contained system that minimizes handling errors and contamination concerns."

The National Institutes of Health's Intramural Sequencing Center already operates both the Illumina Genome Analyzer and the HiSeq, and the solicitation request cites the ability to use the same chemistry and data analysis that the NISC uses for those systems as a requirement for purchase.

The Scan

Influence of Luck

The New York Times examines how the US avoided variant-fueled increases in COVID-19 cases.

PLOS Papers on Retina GWAS, Hantaan Virus, COVID-19 Phenome-Wide Association Study

In PLOS this week: genome-wide association study of retinal morphology, analysis of hantaan virus found in a mouse, and more.

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.